Gillian C. Ivers-Read
2012
In 2012, Gillian C. Ivers-Read earned a total compensation of $1.3M as EVP of Technical Operations and Chief Regulatory Officer at Clovis Oncology, a 94% increase compared to previous year.
Compensation breakdown
| Bonus | $115,360 |
|---|---|
| Option Awards | $784,435 |
| Salary | $358,750 |
| Other | $24,383 |
| Total | $1,282,928 |
Ivers-Read received $784.4K in option awards, accounting for 61% of the total pay in 2012.
Ivers-Read also received $115.4K in bonus, $358.8K in salary and $24.4K in other compensation.
Rankings
In 2012, Gillian C. Ivers-Read's compensation ranked 5,157th out of 11,487 executives tracked by ExecPay. In other words, Ivers-Read earned more than 55.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,157 out of 11,487 | 55th |
Division Manufacturing | 1,802 out of 4,253 | 58th |
Major group Chemicals And Allied Products | 432 out of 1,203 | 64th |
Industry group Drugs | 283 out of 925 | 69th |
Industry Pharmaceutical Preparations | 222 out of 700 | 68th |
Source: SEC filing on April 30, 2015.
Ivers-Read's colleagues
We found four more compensation records of executives who worked with Gillian C. Ivers-Read at Clovis Oncology in 2012.
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019